衰弱对吊带手术伴或不伴脱垂修复结局的影响
基于NSQIP 2013-2016数据,分析25,887例女性吊带手术患者,其中15,087例单纯吊带(组1),10,800例吊带联合脱垂修复(组2)。组1衰弱患病率9.3%,组2为10.2%(p=0.0122)。衰弱与单纯吊带术后住院时间延长(OR 1.2, 95%CI 1.1-1.4, p=0.0008)和30天再入院(OR 1.7, 95%CI 1.1-2.5, p=0.0093)相关;联合脱垂修复中衰弱与再入院相关(OR 1.8, 95%CI 1.3-2.6, p=0.0003),而年龄无显著关联。
要点
- 吊带手术女性中衰弱患病率约9.3%-10.2%。
- 衰弱与单纯吊带术后住院时间延长和30天再入院风险增加相关。
- 衰弱而非年龄与吊带联合脱垂修复术后30天再入院显著相关。
核心结论
- 衰弱在吊带手术患者中相对少见,但衰弱而非年龄与术后30天再入院显著相关。
研究设计与样本
- 回顾性队列分析美国外科医师学会NSQIP 2013-2016数据,纳入25,887例接受吊带放置(CPT 57288)的女性。
- 按是否行孤立吊带或吊带联合脱垂修复分为两组,采用5因子改良衰弱指数(mFI-5≥2)定义衰弱。
- 使用logistic回归模型调整年龄、种族/民族、体质指数和衰弱。
主要发现
- 组1(孤立吊带)衰弱患病率9.3%,组2(联合脱垂修复)为10.2%(p=0.0122)。
- 孤立吊带组中,衰弱与住院时间延长(OR 1.2, 95%CI 1.1-1.4, p=0.0008)和30天再入院(OR 1.7, 95%CI 1.1-2.5, p=0.0093)相关。
- 孤立吊带组中,高龄与更长手术时间(OR 1.2, 95%CI 1.1-1.3, p<0.0001)和住院时间(OR 1.3, 95%CI 1.2-1.4, p<0.0001)相关。
- 联合脱垂修复组中,衰弱与30天再入院相关(OR 1.8, 95%CI 1.3-2.6, p=0.0003),年龄无显著关联(OR 0.9, 95%CI 0.7-1.1, p=0.29)。
关键数值与推荐
- 衰弱定义:mFI-5中≥2个因素存在。
- 孤立吊带组衰弱与住院时间延长OR 1.2(95%CI 1.1-1.4, p=0.0008),30天再入院OR 1.7(95%CI 1.1-2.5, p=0.0093)。
- 联合脱垂修复组衰弱与30天再入院OR 1.8(95%CI 1.3-2.6, p=0.0003)。
临床怎么用
- 术前应识别衰弱患者,尤其计划行吊带联合脱垂修复者,以评估再入院风险。
- 对衰弱患者可加强围手术期管理及出院后随访,降低再入院可能。
局限性
- 回顾性研究设计,仅纳入NSQIP数据,可能存在未测量混杂。
- 衰弱定义基于mFI-5,可能低估或高估实际衰弱状态。
- 仅捕获30天内结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Frailty has emerged as a significant predictor of morbidity in urological surgery, but its impact on outcomes of sling surgery for stress incontinence remains unclear. The purpose of this study is to describe the prevalence of frailty among women undergoing sling surgery and determine the association of frailty with 30-day postoperative outcomes. MATERIALS AND METHODS: We analyzed data from the American College of Surgeons National Surgical Quality Improvement Project (NSQIP®) in 2013-2016 to identify patients undergoing sling placement using Current Procedural Terminology, 10th edition, code 57288. Patients were categorized into 2 groups based on whether they underwent isolated sling placement or had a sling with concomitant prolapse surgery. Frailty was assessed using the 5-factor Modified Frailty Index (mFI-5) developed for use with the NSQIP data set. Patients were considered frail if 2 or more factors from the mFI-5 were present. Outcomes and complications within 30 days were captured from the NSQIP data and logistic regression models used to adjust for age, race/ethnicity, body mass index and frailty. RESULTS: We identified 25,887 women who underwent sling placement, 15,087 of whom underwent isolated sling placement (Group 1) and 10,800 of whom underwent sling with concomitant prolapse repair surgery (Group 2). Frailty was present in 9.3% of patients in Group 1 and 10.2% of patients in Group 2 (p=0.0122). Among those who underwent isolated sling placement, frailty was associated with increased length of hospital stay (OR 1.2, 95% CI 1.1-1.4, p=0.0008) and 30-day hospital readmission (OR 1.7, 95% CI 1.1-2.5, p=0.0093). Older patients undergoing isolated sling placement were more likely to have longer operation time (OR 1.2, 95% CI 1.1-1.3, p <0.0001) and hospital length of stay (OR 1.3, 95% CI 1.2-1.4, p <0.0001). Frailty was also associated with increased 30-day hospital readmission in patients who underwent sling with concomitant prolapse repair (OR 1.8, 95% CI 1.3-2.6, p=0.0003), while age was not (OR 0.9, 95% CI 0.7-1.1, p=0.29). CONCLUSIONS: We found that frailty was present in relatively few patients undergoing sling surgery. Adverse postoperative outcomes and complications were low overall. Increased age and frailty were both associated with longer length of stay. Frailty, but not age, was significantly associated with increased likelihood of hospital readmission within 30 days following surgery. Our findings provide insight into the preoperative characteristics of women undergoing sling surgery in a large national sample, suggesting the need for preoperative identification of the frail patient.
引用
- Medendorp AR, Liu H, Kwan L, et al. The Impact of Frailty on Outcomes of Sling Surgery with and without Prolapse Repair. J Urol. 2021. PMID: 33793295. doi:10.1097/JU.0000000000001769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。